Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach

NCT03933696 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT03933696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03933696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2019
Completion date
May 31, 2025
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment, type2 diabetes